Medical Innovations Incubator GmbH - Tübingen
  • About Us
    • Our approach
    • Team
    • Partner
    • Contact
    • Press
  • Startups
    • 4C Services
    • 4C Grant Editor
    • 4C Accelerator
    • Fundraising
    • Startup BW Pre-Seed
    • Portfolio
  • Corporates
    • Corporate Services
    • Innovation Promotion
  • References
  • Events
    • 4C Close-up
    • 4C Unplugged
    • 4C Panels
  • Blog
  • Newsletter
  • English
  • Deutsch
Select Page
MII x OSORA – Faster go-to-market and why the medical device is now at the end of the roadmap

MII x OSORA – Faster go-to-market and why the medical device is now at the end of the roadmap

by Ingo Hämmerle | Jan 9, 2024 | Case Study (EN), Startups

 Case Study | Projekt mit OSORA medical GmbH OSORA has gathered a variety of starting points for market entry in order to position the technology for bone healing simulation. Market segments exist in the areas of education and training, implant development and...
MII x Fysor – How an idea became the product “Apelvo”

MII x Fysor – How an idea became the product “Apelvo”

by Ingo Hämmerle | Oct 27, 2023 | Case Study (EN), Startups

 Case Study | Project with Fysor GmbH An innovative product idea with a pure training approach can be launched on the market as a lifestyle product. But such a business model must also take into account the requirements and opportunities of the 4Cs in order to be...
MII x sync2brain – From business model development to a certified legal manufacturer

MII x sync2brain – From business model development to a certified legal manufacturer

by Ingo Hämmerle | Oct 23, 2023 | Case Study (EN), Startups

 Case Study | Project with sync2brain GmbH Medical innovations often emerge from research and are driven by a scientific perspective. However, in order for such product ideas to actually reach patients, a market-oriented view must be developed. This was the challenge...
MII x Erbe Elektromedizin – Bringing valuable medical innovations into use despite strategy change

MII x Erbe Elektromedizin – Bringing valuable medical innovations into use despite strategy change

by Ingo Hämmerle | Jul 27, 2023 | Case Study (EN), Corporates

 Case Study | Project with Erbe Elktromedizin GmbH Highly innovative companies are often spoilt for choice: which technologies have potential and strengthen the overall strategy? Which ideas are valuable but create inefficiencies in implementation and should not be...

Recent Posts

  • QMS According to ISO 13485: From Regulatory Obligation to Strategic Success Factor
  • 4C Unplugged 2025 – Where Innovation Meets Networking
  • 4C Unplugged 2025 – Looking Forward to October 16
  • You Can’t Be What You Can’t See!
  • MII x IntegraSkin – Aligning business model with regulatory requirements

Recent Comments

    Designed by Elegant Themes | Powered by WordPress